Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin and Bevacizumab for Breast Cancer Brain Metastases
NCT01004172Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Nov 2009
- Primary completion
- Dec 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in breast cancer, sponsored by Dana-Farber Cancer Institute. Started Nov 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01004172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01004172.